These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 545425)

  • 1. Psychological factors in the prognosis of malignant melanoma: a prospective study.
    Rogentine GN; van Kammen DP; Fox BH; Docherty JP; Rosenblatt JE; Boyd SC; Bunney WE
    Psychosom Med; 1979 Dec; 41(8):647-55. PubMed ID: 545425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness.
    Kelly B; Raphael B; Smithers M; Swanson C; Reid C; McLeod R; Thomson D; Walpole E
    Gen Hosp Psychiatry; 1995 Mar; 17(2):126-34. PubMed ID: 7789783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
    Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
    Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
    Tas F; Erturk K
    Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
    Reintgen DS; Cox C; Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality and disease outcome in malignant melanoma.
    Canada AL; Fawzy NW; Fawzy FI
    J Psychosom Res; 2005 Jan; 58(1):19-27. PubMed ID: 15771866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of psychological variables in a group of melanoma patients. An Israeli sample.
    Baider L; Perry S; Sison A; Holland J; Uziely B; DeNour AK
    Psychosomatics; 1997; 38(1):45-53. PubMed ID: 8997116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial aspects of melanoma.
    Gibertini M; Reintgen DS; Baile WF
    Ann Plast Surg; 1992 Jan; 28(1):17-21. PubMed ID: 1642400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response.
    Temoshok L
    Soc Sci Med; 1985; 20(8):833-40. PubMed ID: 4001992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective and subjective stressors and the psychological adjustment of melanoma survivors.
    Hamama-Raz Y; Solomon Z; Schachter J; Azizi E
    Psychooncology; 2007 Apr; 16(4):287-94. PubMed ID: 16858669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
    Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
    Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma.
    Bergenmar M; Nilsson B; Hansson J; Brandberg Y
    Acta Oncol; 2004; 43(2):161-8. PubMed ID: 15163164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of level V malignant melanoma.
    Bear HD; Neifeld JP; Kay S
    Cancer; 1985 Mar; 55(6):1167-71. PubMed ID: 3971289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy.
    Khosrotehrani K; van der Ploeg AP; Siskind V; Hughes MC; Wright A; Thomas J; Barbour A; Allan C; Bayley G; Eggermont A; Verhoef C; Smithers BM; Green AC
    Eur J Cancer; 2014 May; 50(7):1301-9. PubMed ID: 24613127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
    Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
    Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.